D.E. Shaw & Co’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $528K | Sell |
81,303
-1,767
| -2% | -$11.5K | ﹤0.01% | 2503 |
|
|
2025
Q1 | $659K | Sell |
83,070
-63,315
| -43% | -$502K | ﹤0.01% | 2354 |
|
|
2024
Q4 | $1.85M | Buy |
146,385
+3,250
| +2% | +$41.2K | ﹤0.01% | 1846 |
|
|
2024
Q3 | $1.99M | Sell |
143,135
-81,205
| -36% | -$1.13M | ﹤0.01% | 1802 |
|
|
2024
Q2 | $3.09M | Buy |
224,340
+121
| +0.1% | +$1.67K | ﹤0.01% | 1515 |
|
|
2024
Q1 | $3.7M | Buy |
224,219
+28,730
| +15% | +$475K | ﹤0.01% | 1432 |
|
|
2023
Q4 | $2.85M | Sell |
195,489
-739
| -0.4% | -$10.8K | ﹤0.01% | 1548 |
|
|
2023
Q3 | $2.41M | Sell |
196,228
-17,188
| -8% | -$211K | ﹤0.01% | 1621 |
|
|
2023
Q2 | $2.55M | Sell |
213,416
-210,963
| -50% | -$2.52M | ﹤0.01% | 1617 |
|
|
2023
Q1 | $5.67M | Sell |
424,379
-176,943
| -29% | -$2.37M | 0.01% | 1263 |
|
|
2022
Q4 | $12.9M | Buy |
601,322
+34,174
| +6% | +$735K | 0.01% | 816 |
|
|
2022
Q3 | $11.4M | Buy |
567,148
+428,830
| +310% | +$8.59M | 0.01% | 830 |
|
|
2022
Q2 | $2.48M | Buy |
+138,318
| New | +$2.48M | ﹤0.01% | 2123 |
|
|
2022
Q1 | – | Sell |
-13,404
| Closed | -$226K | – | 4293 |
|
|
2021
Q4 | $226K | Buy |
+13,404
| New | +$226K | ﹤0.01% | 3436 |
|